We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DTV
376
DELISTED
DIRECTV COM STK (DE)
DTV
| $6M | 0.04% |
+70,539
| New | +$6.09M |
|
|
AJRD
377
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $5.97M | 0.04% |
+257,301
| New | +$4.96M |
|
|
K
378
DELISTED
Kellanova
K
| $5.92M | 0.04% |
+95,684
| New | +$5.85M |
|
379
Lumen
LUMN
$6.44B
| $5.84M | 0.04% |
+169,101
| New | +$6.32M |
|
380
British American Tobacco
BTI
$128B
| $5.84M | 0.04% |
+112,474
| New | +$6.24M |
|
|
ATML
381
DELISTED
ATMEL CORP
ATML
| $5.81M | 0.04% |
706,390
+247,718
| +54% | +$2.08M |
|
382
SBA Communications
SBAC
$19.5B
| $5.75M | 0.04% |
49,074
+43,640
| +803% | +$5.15M |
|
383
Timken Company
TKR
$9.03B
| $5.72M | 0.04% |
135,825
+5,135
| +4% | +$213K |
|
384
Intrepid Potash
IPI
$469M
| $5.62M | 0.03% |
48,672
+45,156
| +1,284% | +$5.95M |
|
385
Grupo Aeroportuario del Pacifico
PAC
$13.3B
| $5.58M | 0.03% |
85,082
-87,417
| -51% | -$5.75M |
|
386
Zumiez
ZUMZ
$339M
| $5.56M | 0.03% |
138,128
+96,826
| +234% | +$3.75M |
|
387
HNI Corp
HNI
$3.59B
| $5.56M | 0.03% |
100,744
-21,680
| -18% | -$1.11M |
|
388
Highwoods Properties
HIW
$3.47B
| $5.51M | 0.03% |
120,476
+106,257
| +747% | +$4.89M |
|
389
RELX
RELX
$62B
| $5.51M | 0.03% |
320,188
+172,736
| +117% | +$3M |
|
390
Texas Roadhouse
TXRH
$13.7B
| $5.5M | 0.03% |
151,047
+97,830
| +184% | +$3.47M |
|
391
Molson Coors Class B
TAP
$8.09B
| $5.49M | 0.03% |
73,795
+69,241
| +1,520% | +$5.22M |
|
392
Globe Life
GL
$14.3B
| $5.47M | 0.03% |
99,601
+2,258
| +2% | +$120K |
|
393
The GEO Group
GEO
$4.04B
| $5.41M | 0.03% |
185,634
+62,550
| +51% | +$1.78M |
|
|
MBLY
394
DELISTED
Mobileye N.V.
MBLY
| $5.4M | 0.03% |
128,558
+115,805
| +908% | +$4.51M |
|
395
Morgan Stanley
MS
$340B
| $5.37M | 0.03% |
150,570
-1,314,926
| -90% | -$47.2M |
|
|
BERY
396
DELISTED
Berry Global Group, Inc.
BERY
| $5.36M | 0.03% |
161,318
+149,566
| +1,273% | +$4.7M |
|
|
PF
397
DELISTED
Pinnacle Foods, Inc.
PF
| $5.35M | 0.03% |
131,205
-5,088
| -4% | -$188K |
|
398
United Fire Group
UFCS
$1.4B
| $5.33M | 0.03% |
167,920
| – | – |
|
399
Semtech
SMTC
$13B
| $5.29M | 0.03% |
198,552
+180,377
| +992% | +$4.92M |
|
400
AMC Global Media
AMCX
$489M
| $5.29M | 0.03% |
69,016
+302
| +0.4% | +$20.9K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.